Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Pre-clinical research

Verapamil increases anti-tuberculosis activity of bedaquiline

The calcium channel blocker could allow lower doses of bedaquiline to be used, reducing its toxic effects.

Verapamil increases anti-tuberculosis activity of bedaquiline

Source: Shutterstock.com

The anti-tuberculosis activity of bedaquiline was enhanced by the addition of verapamil

Recently approved bedaquiline is an effective but toxic treatment for multidrug-resistant tuberculosis. Researchers at the Johns Hopkins University School of Medicine in Baltimore, Maryland, have shown that giving lower doses of the drug to mice along with the calcium channel blocker verapamil can result in the same antibacterial effects as the full human bioequivalent dose of bedaquiline[1]. Verapamil also protected against the development of resistant mutants in vivo.

Previous studies have shown that verapamil inhibits bacterial efflux pumps from expelling antibiotics and thereby reduces the chance of antimicrobial resistance developing.

“Shortening treatment regimens and reducing the required doses may be a promising strategy to reduce the incidence of bedaquiline-related adverse effects and thereby improve multidrug-resistant TB treatment outcomes,” says Shashank Gupta, a researcher at Johns Hopkins.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067511

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Verapamil increases anti-tuberculosis activity of bedaquiline

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.